Status:
COMPLETED
Cardioprotective Properties of ELAIOTSIPOURA
Lead Sponsor:
Harokopio University
Collaborating Sponsors:
Nireus Aquaculture
University of Thessaly
Conditions:
Cardiometabolic Health
Eligibility:
All Genders
35-70 years
Phase:
NA
Brief Summary
Several studies over the last decades have demonstrated the important role of nutrition for either the prevention of chronic diseases, such as cardiovascular disease and cancer, or the increase of the...
Detailed Description
Cardiovascular diseases (CVD) represent a major public health challenge and the leading cause of mortality worldwide. The elucidation of CVD pathogenesis, as well as the identification of efficient st...
Eligibility Criteria
Inclusion
- Age 35-70 years old
- Body mass index 25-35 kg/m2
- Habitual fish consumption ≤1 portion/week (1 portion: 150 g cooked fish)
Exclusion
- Presence of diabetes mellitus, active cancer, cardiovascular disease, chronic inflammatory or psychiatric diseases
- Reception of antidiabetic, anxiolytic, antidepressant or cortisol medication
- Habitual excessive alcohol intake (\>210 g of ethanol/week for men and \>140 g of ethanol/week for women)
- Currently on a weight-loss diet or recent change (within 6 months) in lifestyle habits
Key Trial Info
Start Date :
October 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04440202
Start Date
October 18 2021
End Date
July 30 2022
Last Update
July 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University
Kallithea, Attica, Greece, 17671